Manipal Hospital

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Alzheimer disease1 trial
• Bladder cancer1 trial
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Liver and biliary tract cancer1 trial
• Metastatic breast cancer1 trial
• Ovarian cancer1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 43 trials

Status

• Active, not recruiting3 trials
• Completed2 trials
• Not yet recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Hoffmann-La Roche3 trials
• Amgen1 trial
• Christian Medical College and Hospital, Ludhiana, India1 trial
• Eli Lilly and Company1 trial
• Pfizer1 trial
• and 1 more

Running trials

• Not yet recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

  NCT07838155· Phase 4· Eli Lilly and Company· Source

  Contact: Pramod Krishnan (principal investigator)

• Recruiting

  Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease

  NCT05829889· Seung-Jung Park· Source

  Contact: Singh Chadha Davinder, MD

• Recruiting

  Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage

  NCT05836831· Phase 4· Christian Medical College and Hospital, Ludhiana, India· Source

  Contact: Pramod Krishnan, MD DM

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

  NCT05296798· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

  NCT03633708· Phase 3· Amgen· Source

• Active, not recruiting

  A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC

  NCT03052608· Phase 3· Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting
• Coronary artery disease1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

  NCT03782207· Hoffmann-La Roche· Source

• Completed

  An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

  NCT01932125· Phase 4· Hoffmann-La Roche· Source